We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Name | Symbol | Market | Type |
---|---|---|---|
Avid Bioservices Inc | NASDAQ:CDMOP | NASDAQ | Preference Share |
Price Change | % Change | Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 25.06 | 18.00 | 26.00 | 0 | 01:00:00 |
Mr. Alston has more than 15 years of experience spanning operational and capital management responsibilities supporting cGMP manufacturing, facilities, engineering, and environmental, health and safety (EHS) functions. Prior to joining Avid in 2019, Mr. Alston was associate director, engineering and facilities with Sterogene Bioseperations, where he led the biotechnology company’s engineering, facilities, maintenance, safety and environmental functions. During this time, he led the design, construction and launch of Sterogene’s new, more than $5 million cGMP laboratory and pilot plant manufacturing facility. Mr. Alston has also previously served in senior roles within Merck’s viral vaccine manufacturing unit, including senior manufacturing supervisor. His career has included senior engineering, facilities and operational management positions with Unilever and ConAgra Foods.
“Michael’s promotion to vice president, operations, is well deserved based on the exceptional job he has done leading and overseeing our multiple facility expansion and buildout projects, which are complex and occurring concurrently. His extensive background in both engineering and operations is ideally suited for his new role and the responsibilities that come with the position. We are thrilled to be able to promote such a talented individual from within Avid to this key role and look forward to Michael’s continued contributions to the company’s success,” said Nick Green, president and chief executive officer of Avid Bioservices.
About Avid Bioservices, Inc.
Avid Bioservices (NASDAQ:CDMO), an S&P SmallCap 600 company, is a dedicated contract development and manufacturing organization (CDMO) focused on development and CGMP manufacturing of biologics. The company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. With 29 years of experience producing monoclonal antibodies and recombinant proteins, Avid's services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the company provides a variety of process development activities, including upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of our services ranges from standalone process development projects to full development and manufacturing programs through commercialization. www.avidbio.com
Contacts: Stephanie Diaz (Investors) Vida Strategic Partners 415-675-7401 sdiaz@vidasp.com Tim Brons (Media) Vida Strategic Partners 415-675-7402 tbrons@vidasp.com
1 Year Avid Bioservices Chart |
1 Month Avid Bioservices Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions